$4.85 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 127 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 4.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NUVALENT INC | $262,264,000 | -2.4% | 19,341,024 | 0.0% | 5.41% | -9.9% | ||
| VTRS | VIATRIS INC | $216,454,000 | -3.8% | 20,673,700 | 0.0% | 4.46% | -11.2% | |
| INVITAE CORPnote 2.000% 9/0 | $163,025,000 | -4.0% | 206,873,000 | 0.0% | 3.36% | -11.4% | ||
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $133,036,000 | -6.2% | 157,390,000 | 0.0% | 2.74% | -13.5% | ||
| NATERA INCnote 2.250% 5/0 | $111,924,000 | -6.9% | 90,638,000 | 0.0% | 2.31% | -14.1% | ||
| SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $111,766,000 | -3.8% | 88,657,000 | 0.0% | 2.30% | -11.2% | ||
| ENVISTA HOLDINGS CORPORATIONnote 2.375% 6/0 | $100,380,000 | -19.0% | 52,500,000 | 0.0% | 2.07% | -25.3% | ||
| NUVASIVE INCnote 1.000% 6/0 | $93,615,000 | -2.9% | 96,966,000 | 0.0% | 1.93% | -10.4% | ||
| PACIRA BIOSCIENCES INCnote 0.750% 8/0 | $84,967,000 | -15.8% | 81,600,000 | 0.0% | 1.75% | -22.3% | ||
| APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $76,456,000 | -6.4% | 51,885,000 | 0.0% | 1.58% | -13.7% | ||
| NUVASIVE INCnote 0.375% 3/1 | $71,655,000 | -5.9% | 80,000,000 | 0.0% | 1.48% | -13.2% | ||
| INSMED INCnote 1.750% 1/1 | $70,460,000 | -6.0% | 75,000,000 | 0.0% | 1.45% | -13.3% | ||
| INSULET CORPnote 0.375% 9/0 | $66,018,000 | -13.4% | 57,581,000 | 0.0% | 1.36% | -20.1% | ||
| NEVRO CORPnote 2.750% 4/0 | $57,724,000 | -11.7% | 61,000,000 | 0.0% | 1.19% | -18.5% | ||
| CMAX | CAREMAX INC | $57,576,000 | -52.7% | 15,861,090 | 0.0% | 1.19% | -56.4% | |
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $56,158,000 | +6.0% | 57,791,000 | 0.0% | 1.16% | -2.3% | ||
| AERI | AERIE PHARMACEUTICALS INC | $35,213,000 | -17.6% | 4,695,020 | 0.0% | 0.73% | -24.0% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $31,308,000 | -17.9% | 3,933,137 | 0.0% | 0.65% | -24.3% | |
| NOVAVAX INCnote 3.750% 2/0 | $24,855,000 | -7.2% | 25,000,000 | 0.0% | 0.51% | -14.4% | ||
| XERIS BIOPHARMA HOLDINGS INCnote 5.000% 7/1 | $17,607,000 | -16.5% | 18,000,000 | 0.0% | 0.36% | -23.1% | ||
| RVMD | REVOLUTION MEDICINES INC | $17,377,000 | -23.6% | 891,587 | 0.0% | 0.36% | -29.5% | |
| DA32 LIFE SCNCE TEC ACQSTN C | $15,504,000 | -0.3% | 1,600,000 | 0.0% | 0.32% | -8.0% | ||
| HEALTH CATALYST INCnote 2.500% 4/1 | $13,452,000 | -21.7% | 15,000,000 | 0.0% | 0.28% | -27.9% | ||
| PROF | PROFOUND MED CORP | $12,494,000 | -19.0% | 1,713,797 | 0.0% | 0.26% | -25.2% | |
| LRMR | LARIMAR THERAPEUTICS INC | $11,427,000 | -51.6% | 5,830,249 | 0.0% | 0.24% | -55.3% | |
| ALEC | ALECTOR INC | $10,721,000 | -28.7% | 1,055,192 | 0.0% | 0.22% | -34.2% | |
| SRSA | SARISSA CAPITAL ACQUISITN COcl a | $9,890,000 | -0.1% | 999,999 | 0.0% | 0.20% | -7.7% | |
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $9,900,000 | +0.6% | 999,999 | 0.0% | 0.20% | -7.3% | |
| SNRH | SENIOR CONNECT ACQUISITN COR | $9,840,000 | +0.2% | 1,000,000 | 0.0% | 0.20% | -7.7% | |
| MTAC | MEDTECH ACQUISITION CORP | $9,845,000 | +0.5% | 999,999 | 0.0% | 0.20% | -7.3% | |
| REVH | REVOLUTION HEALTHCAR AQ CORP | $9,770,000 | -0.4% | 1,000,000 | 0.0% | 0.20% | -7.8% | |
| TMPM | TURMERIC ACQUISITION CORPcl a | $7,448,000 | +0.8% | 750,000 | 0.0% | 0.15% | -6.7% | |
| IGNY | IGNYTE ACQUISITION CORP | $7,149,000 | +0.2% | 725,000 | 0.0% | 0.15% | -7.5% | |
| APEN | APOLLO ENDOSURGERY INC | $6,388,000 | -39.7% | 1,750,000 | 0.0% | 0.13% | -44.3% | |
| XILIO THERAPEUTICS INC | $6,070,000 | -58.7% | 2,078,692 | 0.0% | 0.12% | -62.0% | ||
| OM | OUTSET MED INC | $5,953,000 | -67.3% | 400,622 | 0.0% | 0.12% | -69.8% | |
| GRAY | GRAYBUG VISION INC | $5,757,000 | -11.4% | 5,281,713 | 0.0% | 0.12% | -17.9% | |
| OHPA | ORION ACQUISITION CORP | $4,900,000 | +0.3% | 500,000 | 0.0% | 0.10% | -7.3% | |
| NYXOAH S A | $4,188,000 | -51.9% | 455,262 | 0.0% | 0.09% | -55.9% | ||
| ORTX | ORCHARD THERAPEUTICS PLCads | $4,060,000 | -17.9% | 6,949,416 | 0.0% | 0.08% | -24.3% | |
| ONCR | ONCORUS INC | $3,968,000 | -29.2% | 3,148,977 | 0.0% | 0.08% | -34.4% | |
| HOWL | WEREWOLF THERAPEUTICS INC | $3,919,000 | -7.0% | 958,125 | 0.0% | 0.08% | -13.8% | |
| QSI | QUANTUM SI INC | $3,248,000 | -50.4% | 1,400,000 | 0.0% | 0.07% | -54.1% | |
| AFIB | ACUTUS MED INC | $2,966,000 | -19.4% | 2,648,386 | 0.0% | 0.06% | -25.6% | |
| ANNX | ANNEXON INC | $2,201,000 | +38.1% | 583,913 | 0.0% | 0.04% | +25.0% | |
| DCTH | DELCATH SYS INC | $1,995,000 | -37.7% | 500,000 | 0.0% | 0.04% | -43.1% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $1,208,000 | -64.0% | 291,005 | 0.0% | 0.02% | -66.7% | |
| THE ONCOLOGY INSTITUTE INC*w exp 11/15/202 | $625,000 | -56.5% | 1,250,000 | 0.0% | 0.01% | -59.4% | ||
| ROIVANT SCIENCES LTD*w exp 09/30/202 | $600,000 | -31.8% | 1,000,000 | 0.0% | 0.01% | -40.0% | ||
| CMAXW | CAREMAX INC*w exp 06/08/202 | $484,000 | -62.1% | 672,000 | 0.0% | 0.01% | -65.5% | |
| CABA | CABALETTA BIO INC | $492,000 | -47.8% | 464,252 | 0.0% | 0.01% | -52.4% | |
| BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $296,000 | -60.4% | 733,333 | 0.0% | 0.01% | -64.7% | |
| QSIAW | QUANTUM SI INC*w exp 06/10/202 | $188,000 | -50.9% | 333,333 | 0.0% | 0.00% | -55.6% | |
| IGNYW | IGNYTE ACQUISITION CORP*w exp 01/05/202 | $76,000 | -42.4% | 362,500 | 0.0% | 0.00% | -33.3% | |
| SOMALOGIC INC*w exp 08/31/202 | $91,000 | -64.6% | 120,000 | 0.0% | 0.00% | -66.7% | ||
| SURROZEN INC*w exp 08/01/203 | $32,000 | -23.8% | 166,666 | 0.0% | 0.00% | 0.0% | ||
| SNRHW | SENIOR CONNECT ACQUISITN COR*w exp 12/31/202 | $35,000 | -61.1% | 500,000 | 0.0% | 0.00% | -50.0% | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $47,000 | -65.2% | 166,666 | 0.0% | 0.00% | -66.7% | |
| MTACW | MEDTECH ACQUISITION CORP*w exp 12/22/202 | $28,000 | -67.1% | 333,333 | 0.0% | 0.00% | -50.0% | |
| REVHW | REVOLUTION HEALTHCAR AQ CORP*w exp 12/31/202 | $49,000 | -45.6% | 200,000 | 0.0% | 0.00% | -50.0% | |
| SRSAW | SARISSA CAPITAL ACQUISITN CO*w exp 10/23/202 | $33,000 | -72.5% | 333,333 | 0.0% | 0.00% | -66.7% | |
| EUCRU | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $0 | – | 1 | 0.0% | 0.00% | – | |
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $22,000 | -64.5% | 333,333 | 0.0% | 0.00% | -100.0% | |
| MTACU | MEDTECH ACQUISITION CORPunit 12/18/2025 | $0 | – | 1 | 0.0% | 0.00% | – | |
| OHPAW | ORION ACQUISITION CORP*w exp 02/19/202 | $11,000 | -71.8% | 125,000 | 0.0% | 0.00% | -100.0% | |
| SRSAU | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $0 | – | 1 | 0.0% | 0.00% | – | |
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $19,000 | -76.8% | 250,000 | 0.0% | 0.00% | -100.0% | |
| WINT | WINDTREE THERAPEUTICS INC | $8,000 | -65.2% | 20,148 | 0.0% | 0.00% | -100.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.